Tested Applications
| Positive WB detected in | A549 cells, A431 cells, HEK-293 cells, HeLa cells |
| Positive IHC detected in | human colon cancer tissue, human skin cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
| Positive IF/ICC detected in | HeLa cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:5000 |
| Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
| Immunofluorescence (IF)/ICC | IF/ICC : 1:400-1:1600 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
10229-1-AP targets SAE1 in WB, IHC, IF/ICC, ELISA applications and shows reactivity with human, mouse, rat samples.
| Tested Reactivity | human, mouse, rat |
| Cited Reactivity | human, mouse |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag0275 Product name: Recombinant human SAE1 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 1-207 aa of BC000344 Sequence: MVEKEEAGGGISEEEAAQYDRQIRLWGLEAQKRLRASRVLLVGLKGLGAEIAKNLILAGVKGLTMLDHEQVTPEDPGAQFLIRTGSVGRNRAEASLERAQNLNPMVDVKVDTEDIEKKPESFFTQFDAVCLTCCSRDVIVKVDQICHKNSIKFFTGDVFGYHGYTFANLGEHEFVEEKTKVAKVSQGVEDGPDTKRAKLDSSETTMV Predict reactive species |
| Full Name | SUMO1 activating enzyme subunit 1 |
| Calculated Molecular Weight | 38 kDa |
| Observed Molecular Weight | 38 kDa |
| GenBank Accession Number | BC000344 |
| Gene Symbol | SAE1 |
| Gene ID (NCBI) | 10055 |
| RRID | AB_2182917 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q9UBE0 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
SAE1(SUMO-activating enzyme subunit 1) is also named as AOS1, SUA1, UBLE1A and belongs to the ubiquitin-activating E1 family. SAE1 has a calculated molecular mass of 38 kD. It had an apparent molecular mass of 40 kD by SDS-PAGE. SAE1 and UBA2 form a heterodimer that functions as a SUMO-activating enzyme for the sumoylation of proteins(PMID:9920803). Western blot analysis of synchronized HeLa cells detectes increased AOS1 expression as cells progressed through S phase, followed by a substantial decrease in G2 phase. Immunofluorescence analysis shows AOS1 and UBA2 distributed throughout nuclei, but they are excluded from nucleoli.(PMID:11481243).
Protocols
| Product Specific Protocols | |
|---|---|
| IF protocol for SAE1 antibody 10229-1-AP | Download protocol |
| IHC protocol for SAE1 antibody 10229-1-AP | Download protocol |
| WB protocol for SAE1 antibody 10229-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The SAE1 Polyclonal antibody (Cat# 10229-1-AP) has 9 citations across journals including Nature Communications, Gut Microbes, Current Biology, Biochemical Pharmacology, Oncoimmunology, Current Issues in Molecular Biology, Open Medicine, eLife, and Ecotoxicology and Environmental Safety. Research fields span SUMOylation, steatohepatitis, intestinal inflammation, spermatogenesis, diabetic nephropathy, pancreatic cancer, colorectal cancer, hepatocellular carcinoma, and HIV-1 latency, with applications mainly in WB, IHC, and IF.
| Species | Application | Title |
|---|---|---|
Nat Commun SENP1 prevents steatohepatitis by suppressing RIPK1-driven apoptosis and inflammation | ||
Gut Microbes Staphylococcus warneri dampens SUMOylation and promotes intestinal inflammation. | ||
Biochem Pharmacol Increased SUMO-activating enzyme subunit 1 promotes glycolysis and fibrotic phenotype of diabetic nephropathy | ||
Oncoimmunology Mild microwave hyperthermia promotes mitotic catastrophe, induces time-delayed cGAS-STING activation and restores sensitivity to anti-PDL1 therapy in Pan02 pancreatic cancer model. | ||
Curr Issues Mol Biol SUMO-Activating Enzyme Subunit 1 Is Associated with Poor Prognosis, Tumor Progression, and Radio-Resistance in Colorectal Cancer |

















